• ECL Western Blotting Substrate: Protocol Guidance and QC

  2026-05-19

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase in chemiluminescent Western blot assays. It is optimal for workflows in molecular biology, cancer biology protein analysis, and signal transduction pathway research, but should not be used in fluorescent or radioisotopic detection assays.

• Strategic P2Y11 Antagonism: NF 340 in Translational Research

  2026-05-19

  This thought-leadership article explores the mechanistic and translational impact of selective P2Y11 antagonism by NF 340 (sodium (Z)-N-(3,7-disulfonaphthalen-1-yl)-4-methyl-3-(((Z)-((2-methyl-5-((Z)-oxido((3-sulfo-7-sulfonatonaphthalen-1-yl)imino)methyl)phenyl)imino)oxidomethyl)amino)benzimidate), with a focus on breast cancer invasiveness and broader implications for immunology and inflammation research. Integrating recent peer-reviewed evidence and competitive insights, it provides actionable guidance for translational scientists seeking robust, reproducible modulation of GPCR signaling.

• IGF2BP3–FZD1/7 Axis Drives Stemness and Drug Resistance in T

  2026-05-18

  This study uncovers how IGF2BP3 stabilizes FZD1/7 mRNAs through m6A-dependent binding, driving cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). Targeting the IGF2BP3–FZD1/7–β-catenin pathway may sensitize TNBC to chemotherapy, presenting a promising route for improved treatment strategies.

• Rapamycin (Sirolimus): Applied Workflows for mTOR Inhibition

  2026-05-18

  Explore how Rapamycin (Sirolimus) enables precise mTOR modulation across cancer, immunology, and neurodegenerative disease models. This guide translates bench research and recent reference breakthroughs into stepwise protocols, troubleshooting insights, and application-driven optimizations for reliable results.

• LuQi Formula Reduces Post-MI Ventricular Remodeling via SPTL

  2026-05-17

  This study demonstrates that the LuQi formula attenuates ventricular remodeling after myocardial infarction by targeting SPTLC2-mediated de novo ceramide synthesis. The findings establish a mechanistic link between sphingolipid metabolism and cardiac repair, offering new directions for targeted heart failure interventions.

• Streptozotocin (STZ): Precision β-Cell Cytotoxicity and Next

  2026-05-16

  Explore Streptozotocin’s advanced role in inducing experimental diabetes, with a detailed focus on β-cell apoptosis, neuroinflammatory mechanisms, and optimized protocol strategies. This article provides new practical and mechanistic insights for diabetes research.

• Paeoniflorin Modulates Tmem176b+ Macrophages in Liver I/R In

  2026-05-15

  This study demonstrates that paeoniflorin mitigates hepatic ischemia-reperfusion injury by directing Tmem176b+ macrophage polarization toward a reparative phenotype. Leveraging single-cell RNA sequencing, the authors reveal a mechanistic link between paeoniflorin, specific macrophage subsets, and key immunoregulatory pathways, offering a foundation for targeted hepatic I/R interventions.

• P2Y11 Antagonism: New Horizons in Cancer and Immunology Rese

  2026-05-15

  This article explores the mechanistic underpinnings and translational value of targeting the P2Y11 receptor with NF 340, a highly selective antagonist. We connect recent advances in purinergic signaling and GPCR pathway research to actionable guidance for translational scientists, with a focus on breast cancer invasiveness and inflammation pathway modulation. By grounding recommendations in recent literature and competitive landscape analysis, this piece offers a unique, strategically oriented perspective and practical protocol advice, setting itself apart from routine product descriptions.

• EdU Imaging Kits (HF488): DNA Synthesis and Proliferation As

  2026-05-14

  EdU Imaging Kits (HF488) enable direct, sensitive detection of DNA synthesis during S-phase, providing a robust cell proliferation assay. The kit’s click chemistry approach preserves cell structure and outperforms traditional BrdU assays for both fluorescence microscopy and flow cytometry applications.

• Super-Enhancer–FOXA1–SLC7A11 Axis Drives Disulfidptosis in P

  2026-05-14

  This study identifies a super-enhancer-regulated FOXA1–SLC7A11 pathway as a key mediator of disulfidptosis—a distinct form of programmed cell death—in prostate cancer. The findings reveal new mechanistic insights into tumor progression and suggest that targeting this axis may represent a promising intervention strategy in glucose-deprived tumor environments.

• Strategic Leverage of Substance P in Translational Neurobiol

  2026-05-13

  This article delivers an advanced, evidence-backed roadmap for translational researchers exploring Substance P—a canonical tachykinin neuropeptide—as both a mechanistic probe and strategic tool in pain transmission, neuroinflammation, and immune modulation. Bridging mechanistic insight with experimental and analytic rigor, it contextualizes the product's value, addresses spectral interference challenges, and charts new territory for translational impact.

• Tariquidar (XR9576): Precision Tools for Chemoresistance Res

  2026-05-13

  Tariquidar (XR9576) provides robust, selective inhibition of P-glycoprotein, enabling reproducible mechanobiology-driven drug resistance assays—even in high-viscosity tumor models. Discover actionable workflows, troubleshooting insights, and the latest evidence to empower transporter-mediated drug disposition studies.

• SB 431542: Strategic Applications in Translational TGF-β Res

  2026-05-12

  This article examines SB 431542’s mechanistic role as a selective ALK5 inhibitor and its transformative impact on translational research, from stem cell differentiation to immuno-oncology. Bridging recent advances in directed cell fate and anti-tumor immunity, we provide evidence-based guidance and protocol parameters for deploying SB 431542 in complex biological systems, and offer a forward-looking perspective on its clinical potential.

• Flavopiridol (A3417): Precision CDK Inhibition in ER Stress

  2026-05-12

  Explore how Flavopiridol (L868275) enables advanced studies of cyclin-dependent kinase inhibition and ER stress interplay. This article uniquely connects molecular mechanisms to optimized workflow decisions, offering actionable insights for cancer research and beyond.

• Aminopeptidase Inhibition Enhances Brain Angiotensin Signali

  2026-05-11

  Harding and Felix (1987) demonstrated that inhibiting aminopeptidases with Bestatin hydrochloride (Ubenimex) dramatically amplifies angiotensin II and III-induced neuronal activity in the rat brain. Their findings clarify the enzymatic conversion required for angiotensin peptide activation, providing mechanistic insight into neuropeptide regulation and experimental strategies in neurobiology.

453 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page